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Abstract
Background: TGF-b has been postulated to play an important role in the maintenance of epithelial homeostasis and the
development of epithelium-derived cancers. However, most of previous studies are mainly focused on the function of TGF-b
in immune cells to the development of allergic asthma and how TGF-b signaling in airway epithelium itself in allergic
inflammation is largely unknown. Furthermore, the in vivo TGF-b function specifically in the airway epithelium during lung
cancer development has been largely elusive.
Methodology/Principal Findings: To evaluate the in vivo contribution of TGF-b signaling in lung epithelium to the
development of allergic disease and lung cancer, we generated a transgenic mouse model with Smad7, an intracellular
inhibitor of TGF-b signaling, constitutively expressed in mouse airway Clara cells using a mouse CC10 promoter. The mice
were subjected to the development of OVA-induced allergic asthma and urethane-induced lung cancer. The Smad7
transgenic animals significantly protected from OVA-induced asthma, with reduced airway inflammation, airway mucus
production, extracellular matrix deposition, and production of OVA-specific IgE. Further analysis of cytokine profiles in lung
homogenates revealed that the Th2 cytokines including IL-4, IL-5 and IL-13, as well as other cytokines including IL-17, IL-1,
IL-6, IP10, G-CSF, and GM-CSF were significantly reduced in the transgenic mice upon OVA induction. In contrast, the Smad7
transgenic animals had an increased incidence of lung carcinogenesis when subjected to urethane treatment.
Conclusion/Significance: These studies, therefore, demonstrate for the first time the in vivo function of TGF-b signaling
specifically in airway epithelium during the development of allergic asthma and lung cancer.
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Introduction
Airway epithelium functions as a complex physical barrier that
defends against exposure to potentially harmful inhaled substances
and microbial pathogens. It is now believed that airway epithelial
cells also play a central role in innate and adaptive immune
response as well as mucosal inflammation that are closely
integrated into the development of allergic airway diseases such
as asthma [1]. Airway epithelial cells produces host defense
molecules, cytokines and chemokines upon activation of pathogen
recognition receptors such as toll-like receptors (TLRs). Epitheli-
um-derived cytokines recruits dendritic cells, T cells and B cells
into close proximity of epithelium to mediate adaptive immune
response through interaction with epithelial cells. On the other
hand, epithelial cells can serve as a target for immune cells,
implicated in the immune response and mucus production in
inflammatory airway diseases. Therefore, further investigation of
functions of epithelial cells in the immune and inflammatory
responses can not only aid in understanding the pathophysiolog-
ical basis of airway diseases, but also help for the future
therapeutical invention of these diseases.
TGF-bs belong to a widely expressed family of cytokines with
pleiotropic effects on a variety of cellular functions such as cell
growth, proliferation, differentiation, and apoptosis. TGF-b
signaling starts by binding of ligand to the cognate transmembrane
receptor kinase, followed by activation of Smad proteins that
transduce the signal from the plasma membrane into the nucleus
where Smad and its transcriptional partners directly regulate gene
expression [2,3]. According to their functional and structural
features, Smads are classified into receptor-specific Smads (R-
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Smads (I-Smads) [3,4].Smad7 is a member of the I-Smad
subfamily that is able to antagonize TGF-b signaling by direct
interaction with the type I receptor [5]. Previous studies have
indicated that TGF-b is implicated in the regulation of airway
inflammation and hyperresponsiveness in asthma development.
Measurement of immunoreactive TGF-b1 in bronchoalveolar
lavage fluid revealed that the basal TGF-b1 level is significantly
elevated in atopic asthma patients and it increases further in
response to allergen exposure.[6] Th2-dominated inflammation is
well illustrated to be the cornerstone of the disorder [7], with
airway remodeling believed to be an adverse consequence of the
inflammatory response [8]. TGF-b secreted by T cells was found
to play an important role in the down-modulation of the immune
response to high doses of antigen [9]. Th cells engineered to
express latent TGF-b abolished airway hyperreacivity and airway
inflammation induced by OVA-specific Th2 effector cells in SCID
and BALB/c mice [10]. And transgenic mice with selective
expression Smad7 in mature T cells to block TGF-b signaling in T
cells enhanced airway inflammation and airway reactivity [11]
However, most of these studies are mainly focused on the function
of TGF-b in immune cells to the development of asthma. How
TGF-b signaling in airway epithelium itself is implicated in allergic
inflammation is largely unknown.
In addition to immune cells, marked activation of epithelial cells
was another important characteristics of allergic diseases and
substantial evidence has demonstrated that epithelial cells are able
to mediate and regulate both innate and adaptive immune
responses [12], indicating that malfunction of epithelia cells is
involved in the initial cause of allergic diseases. The widespread
expression pattern of TGF-bs in epithelial cells suggests that this
family of peptides may play important roles in the maintenance of
epithelial homeostasis. Previous study revealed that expression of
Smad7 in bronchial epithelial cells is inversely correlated to
basement membrane thickness and airway hyperresponsiveness in
patients with asthma [13]. In the asthmatic airway, a positive
correlation between epithelial damage and airway hyperrespon-
siveness has been observed [14], while imbalance between
proliferation and apoptosis of epithelial cells was suggested to
cause an increased loss of parts of the epithelial layer [15]. TGF-b
signaling has previously been shown to induce apoptosis in airway
epithelial cells that indicate TGF-b contributes to the airway
epithelial layer damage in the asthmatic airway [16] However, the
exact function of TGF-b in airway epithelium other than
induction of apoptosis during the development of allergic asthma
remains unclear. To better understand whether or not TGF-b
signaling in epithelial cells contributes to asthma development, we
expressed Smad7 in mouse airway progenitor cells using a mouse
Clara cell specific 10 kDa protein (CC10) promoter to specifically
block TGF-b signaling pathway in airway epithelial cells. Using
the OVA-induced asthma model, we analyzed the role of Smad7
in the development of allergic asthma.
Besides allergic diseases, the other type of severe lung disease is
cancer, which is thought to be a direct consequence of epithelium
malfunction. Alterations in TGF-b signaling have significant
effects on tumor initiation and progression. The function of
TGF-b as a tumor suppressor or tumor promoter dependent on
the context and stage of tumor progression have been carefully
characterized [17]. However, the specific role of TGF-b signaling
in airway epithelial cells in lung cancer progression has been
largely elusive. To better characterize the biological functions of
TGF-b signaling in Clara cells in the development of lung cancer,
we subjected the CC10-Smad7 transgenic mouse with urethane
treatment to induce lung cancer and investigated how TGF-b
signaling in Clara cells might contribute to the development of
lung cancer, in addition to its effect in the development of allergic
asthma.
Results
Generation and characterization of CC10-Smad7
transgenic mice
Smad7 is an inhibitory Smad protein that is able to bind TGF-b
type I receptor and block TGF-b signaling in the cells [5]. To
address the functional significance of TGF-b signaling in airway
epithelium in allergic airways disease and lung carcinogenesis, we
disrupted the in vivo TGF-b signaling by exogenous expression of
Smad7 specifically in the airway epithelium. We generated a
transgenic construct by placing Smad7 under the transcriptional
control of CC10 promoter (CC10-Smad7) to express Smad7
specifically in Clara cells, which are postulated to be pivotal in
forming the cell lineage of the bronchiolar epithelium [18]. A
Myc-tag was constructed at the N-terminus of Smad7 transcript to
facilitate detection of the transgene expression in the animals
(Figure 1A). Previous study showed that the inhibitory activity of
Smad7 was not affected by this Myc-tag. [19]. The plasmid
construct was linearized and used in microinjection to generate the
transgenic mice. The mouse founders were identified by
genotyping using genomic DNA isolated from the mouse tails
(Figure 1B). From a total of 83 offspring in the B6CBF1
background given by the pseudopregnant foster mothers, 8
founders were identified to carry the transgene. All mice positive
for the transgene showed no signs of health problems up to 1 year
of age as compared with the wild type littermates.
To verifying Smad7 transgene expression, RT-PCR was first
performed to detect the expression of exogenous Smad7 with a
pair of primers specific for the transgene as shown in Figure 1A.
The mRNA of the Myc-tagged Smad7 was only detected in the
lung of the transgenic mice, but neither in the lung of the wide
type mice nor in the heart of the transgenic mice (Figure 1C). The
expression of Smad7 protein was later examined by immunohis-
tochemistry staining in the lung sections. As a result, we found that
the protein level of Smad7 was markedly increased in airway
bronchiolar epithelium in transgenic mice in comparison with the
wide type animals (Figure 1D). The mice positive for the Smad7
transgene were crossed with C57BL/6J strain to generate
transgenic mice used in this study. Therefore, all the mice used
in the analyses were 50% B6CBF1 and 50% C57BL/6J in their
genetic background. To confirm that expression of the exogenous
Smad7 is able to block TGF-b signaling, we performed
immunohistochemistry staining to detect the phosphorylation of
Smad2, which is one of the major signaling events after TGF-b
receptor activation[3,4]. As expected, phosphorylation of Smad2
was largely decreased in the Smad7 transgenic animals specifically
in epithelium (Figure 1E).
Overexpression of Smad7 in airway epithelium alleviates
allergic inflammation and airway remodeling
A majority of previous studies have demonstrated that TGF-b
serves as a negative regulator of airway inflammation and
hyperresponsiveness through its regulation on immune cells
[9,10,11,13,20,21]. However, the specific role of TGF-b signaling
in airway epithelium in the development of asthma remains
unknown. To address the issue, both the CC10-Smad7 transgenic
mice and the wild type littermates were induced to develop allergic
asthma by OVA sensitization and challenge (Figure 2A).
One of the major factors in the development of allergen-induced
lung pathophysiology is inflammatory cell infiltration to the
Smad7 in Asthma & Lung Cancer
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lung tissue by examination of H&E-stained histological sections. In
wild type mice, OVA induction led to widespread peribronchiolar
inflammation (Figure 2B, left panel). However, the inflammatory
cell recruitment in CC10-Smad7 transgenic mice was dramatically
decreased (Figure 2B, right panel). Prolonged allergen challenge of
sensitized mice results in increased extracellular matrix deposition
in bronchiolar subepithelial regions [22]. We next analyzed the
function of Smad7 overexpression on extracellular matrix
deposition in lung sections by MSB staining. It appeared that
matrix deposition in the Smad7 transgenic mice was markedly
decreased in comparison with the wide type mice (Figure 2D).
Consistently, PAS staining also revealed that the mucus secretion
was significantly reduced in the Smad7 transgenic mice
(Figure 2C). The production of OVA specific IgE was also
significantly decreased in the Smad7 transgenic mice in compar-
ison with the wild type control (Figure 2E). Collectively, these data
indicate that Smad7 expression in airway epithelial cells was able
to alleviate local inflammation, matrix deposition and mucus
secretion in OVA-induced allergic asthma.
Overexpression of Smad7 in airway epithelium
modulates cytokine profile upon OVA induction
Cytokines were found to play a critical role in orchestrating,
perpetuating and amplifying the inflammatory response in asthma.
The increased and abnormal expression of cytokines in airway
cells is one of the major targets of corticosteroid therapy that is by
far the most effective treatment for asthma currently available. To
further investigate the inflammatory response in OVA-induced
asthma, we analyzed the cytokine profile of the lung homogenates
by ELISA method (Figure 3A). It has been shown that IL-4, IL-5
and IL-13, the well-defined Th2 cytokines, play an important role
in the pathophysiology of allergic diseases including asthma
[23,24] These Th2 cytokines were significantly decreased in
CC10-Smad7 mice compared to the wild type animals. Mean-
while, the Th1 cytokines such as IL-2 and IFN-c had little change
between the two groups. Interestingly, some other cytokines such
as IL-1 and IL-6 that were found to play important roles in many
inflammatory diseases such chronic obstructive pulmonary disease,
inflammatory bowel disease and rheumatoid arthritis, were also
decreased in CC10-Smad7 mice. In contrast, IL-10, a pleiotropic
cytokine that has the potential to downregulate both Th1- and
Th2-driven inflammatory processes [25], and has been shown to
possess a beneficial effect on airway remodeling [26,27], was
significantly increased in CC10-Smad7 mice. MIP-1a, one of the
downstream target of NFkB signaling [28], was decreased in the
Smad7 transgenic mice, indicating a possible downregulation of
NFkB signaling in the transgenic animals. GM-CSF, a key
cytokine for eosinophil survival and being produced by both Th2
and Th1 cells as well as epithelial cells [29,30], was also decreased
in the Smad7 transgenic mice, consistent with the previous finding
that neutralization of GM-CSF with antibodies could attenuate
airway hyper-responsiveness in a murine asthma model [31].
Similar to GM-CSF, another neutrophil factor, G-CSF, was
significantly decreased in CC10-Smad7 transgenic mice. IP-10,
which was found to be involved in human allergic pulmonary
reaction and increased in asthmatic children[32,33], was also
decreased in the transgenic mice, indicating that the cytokine
secretion was extensively changed toward a favorite direction in
the transgenic animals. Another cytokine, IL-17, which was found
to be correlated with the degree of severity of airway hypersen-
sitivity in asthmatic patients [34], was also significantly reduced in
CC10-Smad7 mice (Figure 3A). Further analysis revealed that
TGF-b1 concentration was not significantly changed in CC10-
Smad7 mice (Figure 3B). Collectively, these data not only confirm
that disruption of TGF-b signaling in the lung epithelium is able to
alleviate OVA-induced allergic response in the lung, but may also
indicate that alteration of TGF-b signaling in the epithelium itself
is able to modulate cytokine secretion by either the epithelial cells
or the immune cells recruited to the epithelium.
Overexpression of Smad7 in airway epithelium increased
the incidence of lung carcinogenesis following exposure
to urethane
Alterations in TGF-b signaling are linked to a variety of human
diseases, including cancers[17]. The disruption of TGF-b signaling
occurs in several human cancers and it has been proposed that
TGF-b possesses a tumor suppressor function in the initial phase of
cancer development[17]. Smad6 and Smad7 are two inhibitory
Smad proteins, while Smad7 is relatively specific for blocking
TGF-b signaling and Smad6 is specific for blocking BMP signals.
Smad6 was recently found to contribute to patient survival in non-
small cell lung cancer [35]. However, the contribution of Smad7
specifically in lung epithelium to lung cancer has not been
characterized. In this study, we analyzed whether disruption of
TGF-b signaling specifically in the lung epithelium is implicated in
the development of lung cancer. To address this issue, we
subjected both the wild type and CC10-Smad7 mice to urethane
treatment. Five months after urethane treatment, the mice were
sacrificed and the tumor formation in the lung was analyzed. In
contrast to the protective role of Smad7 on asthma development,
CC10-Smad7 mice showed significantly increased incidence of
lung tumors in comparison with the wild type controls (Figure 4A).
Statistic analysis revealed that the tumor number in CC10-Smad7
mice was about twice of those in the wild type mice in both male
and female animals (Figure 4B). Except for the changes of tumor
incidence, there appeared no discernable difference in the
structural property of the tumor as histological analysis revealed
the same type of adenocarcinoma in both the wide type and
Smad7 transgenic mice (Figure 4C).
Figure 1. Generation of transgenic mouse. (A) A diagram depicting the transgenic construct. A mouse CC10 promoter was placed upstream of a
rat Smad7 cDNA gene. A Myc tag was placed at the N-terminal end of the Smad7 transcript. The relative positions of PCR primers are indicated. (B)
Genotyping of transgenic mice by PCR. Genomic DNA isolated from mouse tails was used in genomic PCR with a pair of primers specific for the
Smad7 transgene, giving rise to a product of 843 bp. A representative result is shown here with five positive samples marked with ‘‘+’’. (C) Expression
of Smad7 transgene mRNA in the mouse lung. Total RNA was isolated from mouse tissues, including lung (L) and heart (H). RT-PCR was performed to
detect the expression of Myc tagged-Smad7 with a pair of primers specific for transgene. Expression of G3PDH (glyceraldehyde-3-phosphate
dehydrogenase) was used as quantity control of cDNA template. A representative result is shown here with two positive samples (#53 and #89) and
a negative sample (#68). The Myc-tagged Smad7 plasmid was used as template for a positive control. (D) Analysis of the Smad7 by
immunohistochemistry staining. Representative lung sections (4006) from wild type and the CC10-Smad7 transgenic mice were used in
immunohistochemistry staining with an anti-Smad7 antibody. The nuclei were stained with haematoxylin. Note the increased expression of Smad7 in
bronchiolar epithelium but not in other cells. (E) Disruption of TGF-b signaling by Smad7 in the transgenic mouse. Representative lung sections
(4006) were used in immunohistochemistry staining with an antibody for phosphorylated Smad2 antibody. The nuclei were stained with
haematoxylin. Note the decreased phosphorylation level of Smad2 in bronchiolar epithelium in the transgenic mouse.
doi:10.1371/journal.pone.0010149.g001
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In this study, we specifically blocked TGF-b signaling in airway
epithelium by overexpression Smad7 in Clara cells. The
contribution of TGF-b signaling specifically in Clara cells in
allergic asthma and lung cancer was investigated. Using the
transgenic mouse model, our studies uncover for the first time the
important function of TGF-b signaling in airway epithelium itself
in the development of allergic asthma and lung cancer. Blocking
TGF-b signaling in Clara cells appears to have a protective role in
OVA-induced asthma, while it can increase the incidence of
urethane-induced lung cancer.
Allergic asthma is a complex disorder and the pathogenesis of
this disease can be regarded as a two-step phenomenon. The first
step consists of sensitization to an aeroallergen and preferential
activation of antigen specific Th2 cells. The second step involves
targeting the Th2-driven allergic inflammation to the lower
airway. The inflammatory process is orchestrated and regulated by
a complex network of mutually interacting cytokines and growth
factors, secreted not only by a range of inflammatory cells but also
by structural tissue components including epithelial cells, fibro-
blasts and smooth muscle cells, subsequently leading to remodeling
of airway wall. In OVA-induced asthma model, CC10-Smad7
transgenic mice showed reduced airway inflammation character-
ized by decreases in immune cell infiltration, extracellular matrix
deposition, mucus production, and production of OVA-specific
IgE. The reduced airway mucus production and extracellular
matrix deposition in the Smad7 transgenic mice revealed a slowed
progression in airway remodeling. Further analysis of several
cytokines in the lung homogenates demonstrated that the local
immune response was significantly alleviated in the transgenic
animals.
Our data uncover for the first time that specifically blocking the
TGF-b signaling by overexpression Smad7 in lung epithelium, but
not in immune cells, is sufficient to relieve the development of
allergic asthma. Previous studies were mainly focused on the
actions of TGF-b in immune cells in the pathophysiology of
asthma. For example, selective expression Smad7 in mature T
cells to block TGF-b signaling in T cells could enhance airway
inflammation and airway reactivity [11]. However, in comparison
with blocking TGF-b signaling in T cells, our results demonstrated
an opposite action of TGF-b pathway in regulating airway
inflammation and expression of many pro-inflammatory cytokines
when TGF-b signaling is selectively blocked in Clara cells. We
postulate that blocking TGF-b signaling pathway specifically in
lung epithelium will affect the epithelium-mediated adaptive
immune response, such as cytokine secretion to recruit immune
cells into the proximity of epithelium during the progression of
inflammatory response. Our data, therefore, reveal that TGF-b
signaling pathway has a different function in regulating airway
inflammation dependent on the context of cell type. In addition,
previous studies have been targeting on the effect of TGF-b
signaling on epithelium apoptosis[16]. However, our data
demonstrate that there is no significant change in cell apoptosis
between the wild type and CC10-Smad7 transgenic mice (Figure
S1), indicating that apoptosis may not play a primary role in TGF-
b-mediated regulation on airway inflammation.
Our analyses with the cytokine profile in the lung homogenates
provided additional evidence that TGF-b signaling in the
epithelium itself is implicated in the development of allergic
response. We found that the well-defined Th2 cytokines, such as
IL-4, IL-5 and IL-13, were significantly decreased in the Smad7
transgenic mouse, indicating that the Th2-driven allergic inflam-
mation is alleviated after disruption of TGF-b signaling in airway
epithelium. It can be postulated that there exists a positive
feedback between the activation of epithelial cells and the Th2
cells, and TGF-b signaling in epithelial cells is implicated in such
positive feedback. Airway epithelial cells can undergo remodeling
changes and contribute to inflammation by producing proin-
flammatory molecules. Indeed, epithelial cells can secrete an array
of proinflammatory molecules that modulate the recruitment and
functioning of immune and inflammatory cells [1]. As cytokines
play a critical role in orchestrating, perpetuating and amplifying
the inflammatory response in asthma, we hypothesize that the
secretion of proinflammatory cytokines, and/or the positive
feedback between epithelial cells and Th2 cells, are partly
controlled by TGF-b signaling in epithelial cells.
In addition to Th2 cytokines, some other cytokines such as IL-1
and IL-6 that have been found to play a role in many
inflammatory diseases, were also reduced in the Smad7 transgenic
mice, indicating that TGF-b signaling in the airway epithelium has
a general effect to modulate local inflammation. Interestingly, we
found that IL-10 is increased in the lung homogenate of CC10-
Smad7 mice. Consistently, IL-10 has been shown to reduce both
Th1- and Th2-driven inflammatory processes [25]. Some other
cytokines that were previously found to be related to asthma
development such as G-CSF, GM-CSF and IP-10, had consistent
change toward a favorite direction in the Smad7 transgenic mice,
indicating a reduced allergic development. To our surprise, IL-17,
that was found to be correlated with the degree and severity of
airway hypersensitivity in asthmatic patients [34], was markedly
reduced in the CC10-Smad7 mice. IL-17 is secreted by Th17 cells
that comprise a recently recognized subset of T cells mediating
immunity to extracellular organisms and being implicated in
several autoimmune diseases [36]. The role of IL17 in animal
model of allergic airway inflammation has been recently
investigated in several studies[37,38]. A dual role has been found
for IL17 and the precise role of IL17 in allergic airway
inflammation is not fully clear. Our study provided a piece of
clue that the secretion of IL-17 may be regulated by TGF-b
signaling in epithelial cells in the development of allergic asthma.
The missing link between TGF-b signaling in epithelial cells and
secretion of IL-17 by Th17 cells would be an interesting and
important issue to investigate in the future.
In contrast to the protective role of Smad7 overexpression in
OVA-induced asthma, blocking TGF-b signaling by overexpres-
Figure 2. Overexpression of Smad7 in airway epithelium alleviates allergic inflammation and airway remodeling. (A) Schematic
presentation of the study protocol for OVA-induced allergic asthma. Airway inflammation and remodeling was induced in female C57BL/6J mice
sensitized with OVA in alum, and subjected to serial aerosolized OVA. (B) Reduced airway inflammation in OVA-sensitized and challenged CC10-
Smad7 mice. Representative sections from paraffin-embedded lung were stained using H&E. Note that the inflammatory cells recruitment was largely
reduced in CC10-Smad7 mice. The magnification of the image is 4006. (C) Reduced airway mucus production in OVA-induced asthma in CC10-Smad7
mice. Representative sections (4006) from paraffin-embedded lung were stained using PAS. Note that that the mucus stained by PSA (reddish-
purple) produced by airway cells was reduced in CC10-Smad7 mice. (D) Decreased airway extracellular matrix deposition in OVA-induced asthma in
CC10-Smad7. Representative sections (4006) from paraffin-embedded lung were stained using MSB. Note the peribronchial fibrosis was decreased in
CC10-Smad7 mice. (E) Reduced OVA-specific IgE concentration in CC10-Smad7 mice. The mouse serum was analyzed for OVA-specific IgE by ELISA.
Values are mean 6 SD from five mice per group.
doi:10.1371/journal.pone.0010149.g002
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incidence of lung carcinogenesis following exposure to urethane.
This result is consistent with numerous previous reports demon-
strating that TGF-b signaling serves as a tumor suppressor
function especially at the initial stage of carcinogenesis. Adeno-
carcinoma is the most common form of human lung cancer, one of
the leading causes of cancer-related deaths worldwide, especially
in the United States [39]. Most adenocarcinomas arise in the
alveolar and bronchiloar epithelia from type II pneumocytes and
Clara cells, and it is mainly those of Clara cells origin that progress
to malignancy.[40]. Whether or not Clara cells have a similar
etiologic function in mouse models of adenocarcinoma is
controversial [41]. Our studies for the first time has highlighted
the contribution of TGF-b signaling specifically in Clara cells to
the development of lung adenocarcinoma in the mouse,
meanwhile providing another proof indicating the important
etiologic function of Clara cells in the development of adenocar-
cinoma. Therefore, the CC10-Smad7 mouse may be used as a
useful model to further elucidate the functional role of Clara cells,
especially the TGF-b signaling in Clara cells, in the development
of lung adenocarcinoma in the future.
The relationship between inflammation and cancer has been
broadly investigated and the general consensus is that chronic and
persistent inflammation may contribute to cancer development
[42,43]. However, this is a controversial issue, especially during
the early phases of carcinogenesis when innate response is
beneficial and likely involved in the activation of effective
surveillance by adaptive immunity to eliminate the affected
cells[44,45]. Genetic and bioinformatic analyses revealed that
oncogene-induced cellular senescence (OIS), a potent cancer-
protective response to oncogenic events, is linked specifically to the
activation of an inflammatory transcriptome [46,47]. IL-6 and IL-
8 have been found to be required for the execution of OIS [46,47].
In certain human tumors, the presence of an effective immune
response is associated with good prognosis [48,49]. As our result
showed that the inflammation response in OVA-induced asthma
was dramatically decreased in CC10-Smad7 mice, we suggest that
the increased incidence of lung carcinogenesis induced by
urethane treatment in these mice may partly due to the alteration
of inflammatory status. However, the underlying mechanism to
comprehend the contribution of TGF-b signaling in epithelium to
allergic disease and cancer development especially the interplay
between allergic response and cancer development needs further
investigation in the future. Nevertheless, the CC10-Smad7 mouse
may serve as a useful model to elucidate these important issues.
Materials and Methods
Ethics Statement
All animals were maintained and used in accordance with the
guidelines of the Institutional Animal Care and Use Committee of
the Institute for Nutritional Sciences, Shanghai Institutes for
Biological Sciences, Chinese Academy of Sciences.
Generation of CC10-Smad7 mice
The Smad7 transgene was constructed by standard recombi-
nant DNA techniques by fusing a mouse CC10 promoter (2.3 kb)
with a Myc-tagged rat Smad7 cDNA (Figure 1A). The mouse
CC10 promoter was cloned from the mouse genomic DNA using
primers: 59-TTGCAGGGAGTAAGGAGGGTCATGGGA-39 and
59-GGCTTTGGTGTCTGTAGATGTGGGGTG-39. The linear-
ized transgene was used in microinjection into fertilized mouse eggs at
the Model Animal Research Center, Nanjing University, Nanjing,
China. All transgenic mice were generated with B6CBF1 and
maintained with the C57B6/6J strain.
Analysis of CC10-Smad7 transgene expression
Genomic DNA was extracted from a 2-mm tail biospy with a
Genomic DNA Extraction protocol as described [50]. PCR
genotyping primers were 59-TCGTTGGAGGGAGGCAATAGA
AGGA-39 and 59-GCGAGGA GGCGAGGAGAAAAGTCGT-
39. To detect the mRNA expression of the Smad7 transgene, mice
were sacrificed and the lung and other tissues were removed and
washed with cold PBS, homogenized, and subjected to Trizol
RNA abstraction. The RNA was reverse-transcribed as described
[51], and the expression of myc-Smad7 was examined by PCR
with primers 59-GAATGAAATGGAGAGCTTGGGCGAC-39
and 59-GAGGATGGGGG ATGGGGATGGTGGT- 39.
Histological analysis
Mouse lung tissues were fixed in 4% polyformaldehyde solution
at 4uC overnight, and then embedded in paraffin. Paraffin sections
of 4 mm were used for hematoxylin and eosin (HE) staining and
immunohistochemistry (IHC). The antibodies were diluted as
follows: phosphorylated Smad2 (1:200) (from Cell Signaling
Technology, Danvers, MA, USA), and Smad7 (1:200) (from Santa
Cruz, CA, USA). TUNEL assay was carried out using ApopTagH
Peroxidase In Situ Apoptosis Detection Kit (from Chemicon,
Temecula, CA, USA) following the instructions.
PAS and MSB staining
PAS and MSB staining was performed as previously described
[52]. For PAS staining, the mouse lung specimens were fixed in
Bouin’s solution overnight at room temperature and embedded in
paraffin using standard techniques. The paraffin-embedded
sections (4 mm) were oxidized in 0.5% periodic acid for 15 min.
After rinsing 3 times with water, the sections were stained with
Schiff’s Reagent for 15 min, then washed with fresh sulfite water
for 5 min. The sections were dehydrated, cleared and mounted.
For MSB staining, the paraffin-embedded sections (at 4 mm) were
oxidized in 1% potassium permanganate for 5 min, rinsed with
water, treated with 2% oxalic acid, stained with Celestine blue for
3 min, and then treated with Mayer’ haematoxylin for 3 min. The
sections were then washed in tap water for 10 min, rinsed in 95%
alcohol, and stained with Martius yellow solution for 30 min. After
washing in water, the sections were stained in 1% rosaniline
trisulfonic acid for 10 min, washed with 1% phosphotungstic acid
for 5–10 minutes or until most of the red dye came out of the
connective tissue, and then stained in methyl blue solution for
2 min. Finally the sections were dehydrated, cleared and mounted.
OVA-induced asthma model
Allergen-induced asthma was induced with eight to nine week
old female CC10-Smad7 transgenic and wild type mice sensitized
with OVA in alum as previously described[50]. Briefly, mice were
sensitized using intraperitoneal injection of 10 mg OVA (Sigma-
Figure 3. Alteration of cytokines in lung homogenate. (A) Changes of cytokines in lung homogenate. Lung homogenate was prepared from
the wild type and CC10-Smad7 mice after OVA-induced asthma formation. Values are shown as means 6 SD. The p-values are also shown. (B) TGF-b
level in lung homogenate. Lung homogenate was prepared from the wild type and CC10-Smad7 mice after OVA-induced asthma formation. Values
are shown as means 6 SD.
doi:10.1371/journal.pone.0010149.g003
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Electrophoresis, Heidelberg,Germany) on days 1 and 14. From
day 21, mice were challenged 30 min/day with aerosolized OVA
(1% w/v) for 5 consecutive days. Mice were sacrificed 24 h after
the last aerosol challenge. Determination of serum OVA-specific
IgE production were conducted as previously described [50].
Urethane-induced lung cancer model
To induce lung adenoma, eight to nine week old male and
female mice (with 50% C57BL/6J and 50% A/J background)
were given a single dose of urethane in 0.9% NaCl (1 mg/g body
weight) intraperitoneally. The mice were sacrificed 5 months after
the injection and the lungs were harvested for analysis.
Lung homogenate and ELISA
The concentrations of cytokine were measured in lung
homogenates by multiplex ELISA (Lincoplex Systems, St Charles,
MO, USA) on a Luminex 200 system using Starstation software
(Applied Cytometry Systems, Sheffield, UK). Following cytokines
were included: IL-1b, IL-2, IL-4, IL-5, IL-6, IL-7, KC (murine
homologue of IL-8), IL-9, IL-12 (p70), IL-17, IFN-c, granulocyte-
macrophage colony-stimulating factor (GM-CSF), granulocyte
colony-stimulating factor (G-CSF), monocyte chemoattractant
protein-1 (MCP-1, also known as JE), macrophage inhibitory
protein-1a (MIP-1a), TNF-a, and RANTES. TGF-b1 was
determined in lung tissue homogenates using a TGF-b Quantikine
Kit according to the instructions of the manufacturer (R&D
Systems, Minneapolis, MN, USA).Briefly, 96-well microtiter plates
were coated overnight at 4uC with 2 mg per well of mouse
capturing mAbs and subsequently blocked at 37uC for 2 hours
with 2% BSA-PBS. After washing with a solution containing
0.02% Tween-20, 50 ml of each sample and its control were added
and incubated for 2 h at ambient temperature simultaneously with
50 ml of a biotinylated detecting antibody (0.25 mg/ml of each
monoclonal antibody) in 2% BSA/PBS/Tween-20. The plates
were washed and incubated for 30 min with streptavidin-
conjugated horseradish peroxidase. 100 ml of 0.0125% tetra-
methylbenzidine and 0.008% H2O2 in citrate buffer was used as
substrate. A standard curve was performed for each plate and used
to calculate the absolute concentrations of cytokines.
Supporting Information
Figure S1
Found at: doi:10.1371/journal.pone.0010149.s001 (0.14 MB
DOC)
Author Contributions
Conceived and designed the experiments: YC. Performed the experiments:
XL QD MW ZL KM. Analyzed the data: XL QD BS YC. Contributed
reagents/materials/analysis tools: YP ZW YQZ. Wrote the paper: XL QD
YC.
References
1. Kato A, Schleimer RP (2007) Beyond inflammation: airway epithelial cells are at
the interface of innate and adaptive immunity. Curr Opin Immunol 19: 711–720.
2. Wrana JL, Attisano L, Carcamo J, Zentella A, Doody J, et al. (1992) TGF beta
signals through a heteromeric protein kinase receptor complex. Cell 71:
1003–1014.
3. Massague J (1998) TGF-beta signal transduction. Annu Rev Biochem 67:
753–791.
4. Heldin CH, Miyazono K, ten Dijke P (1997) TGF-beta signalling from cell
membrane to nucleus through SMAD proteins. Nature 390: 465–471.
5. Hayashi H, Abdollah S, Qiu Y, Cai J, Xu YY, et al. (1997) The MAD-related
protein Smad7 associates with the TGFbeta receptor and functions as an
antagonist of TGFbeta signaling. Cell 89: 1165–1173.
6. Redington AE, Madden J, Frew AJ, Djukanovic R, Roche WR, et al. (1997)
Transforming growth factor-beta 1 in asthma. Measurement in bronchoalveolar
lavage fluid. Am J Respir Crit Care Med 156: 642–647.
7. Ray A, Cohn L (1999) Th2 cells and GATA-3 in asthma: new insights into the
regulation of airway inflammation. J Clin Invest 104: 985–993.
8. Elias JA, Zhu Z, Chupp G, Homer RJ (1999) Airway remodeling in asthma.
J Clin Invest 104: 1001–1006.
9. Haneda K, Sano K, Tamura G, Shirota H, Ohkawara Y, et al. (1999)
Transforming growth factor-beta secreted from CD4(+) T cells ameliorates
antigen-induced eosinophilic inflammation. A novel high-dose tolerance in the
trachea. Am J Respir Cell Mol Biol 21: 268–274.
10. Hansen G, McIntire JJ, Yeung VP, Berry G, Thorbecke GJ, et al. (2000) CD4(+)
T helper cells engineered to produce latent TGF-beta1 reverse allergen-induced
airway hyperreactivity and inflammation. J Clin Invest 105: 61–70.
11. Nakao A, Miike S, Hatano M, Okumura K, Tokuhisa T, et al. (2000) Blockade
of transforming growth factor beta/Smad signaling in T cells by overexpression
of Smad7 enhances antigen-induced airway inflammation and airway reactivity.
J Exp Med 192: 151–158.
12. Schleimer RP, Kato A, Kern R, Kuperman D, Avila PC (2007) Epithelium: at
the interface of innate and adaptive immune responses. J Allergy Clin Immunol
120: 1279–1284.
13. Nakao A, Sagara H, Setoguchi Y, Okada T, Okumura K, et al. (2002)
Expression of Smad7 in bronchial epithelial cells is inversely correlated to
basement membrane thickness and airway hyperresponsiveness in patients with
asthma. J Allergy Clin Immunol 110: 873–878.
14. Boulet LP, Laviolette M, Turcotte H, Cartier A, Dugas M, et al. (1997)
Bronchial subepithelial fibrosis correlates with airway responsiveness to
methacholine. Chest 112: 45–52.
15. Yamauchi K (2006) Airway remodeling in asthma and its influence on clinical
pathophysiology. Tohoku J Exp Med 209: 75–87.
16. Undevia NS, Dorscheid DR, Marroquin BA, Gugliotta WL, Tse R, et al. (2004)
Smad and p38-MAPK signaling mediates apoptotic effects of transforming
growth factor-beta1 in human airway epithelial cells. Am J Physiol Lung Cell
Mol Physiol 287: L515–524.
17. Bierie B, Moses HL (2006) Tumour microenvironment: TGFbeta: the molecular
Jekyll and Hyde of cancer. Nat Rev Cancer 6: 506–520.
18. Balis JU, Paterson JF, Paciga JE, Haller EM, Shelley SA (1985) Distribution and
subcellular localization of surfactant-associated glycoproteins in human lung.
Lab Invest 52: 657–669.
19. Kuang C, Xiao Y, Liu X, Stringfield TM, Zhang S, et al. (2006) In vivo
disruption of TGF-beta signaling by Smad7 leads to premalignant ductal lesions
in the pancreas. Proc Natl Acad Sci U S A 103: 1858–1863.
20. Haneda K, Sano K, Tamura G, Sato T, Habu S, et al. (1997) TGF-beta induced
by oral tolerance ameliorates experimental tracheal eosinophilia. J Immunol
159: 4484–4490.
21. Nakao A (2001) Is TGF-beta1 the key to suppression of human asthma? Trends
Immunol 22: 115–118.
22. McMillan SJ, Lloyd CM (2004) Prolonged allergen challenge in mice leads to
persistent airway remodelling. Clin Exp Allergy 34: 497–507.
23. Barnes PJ (2001) Th2 cytokines and asthma: an introduction. Respir Res 2:
64–65.
24. Chung KF, Barnes PJ (1999) Cytokines in asthma. Thorax 54: 825–857.
25. Koulis A, Robinson DS (2000) The anti-inflammatory effects of interleukin-10 in
allergic disease. Clin Exp Allergy 30: 747–750.
26. Selzman CH, McIntyre RC, Jr., Shames BD, Whitehill TA, Banerjee A, et al.
(1998) Interleukin-10 inhibits human vascular smooth muscle proliferation. J Mol
Cell Cardiol 30: 889–896.
27. Reitamo S, Remitz A, Tamai K, Uitto J (1994) Interleukin-10 modulates type I
collagen and matrix metalloprotease gene expression in cultured human skin
fibroblasts. J Clin Invest 94: 2489–2492.
28. Skaug B, Jiang X, Chen ZJ (2009) The role of ubiquitin in NF-kappaB
regulatory pathways. Annu Rev Biochem 78: 769–796.
Figure 4. Overexpression of Smad7 in airways increased the lung carcinogenesis following exposure to Urethane. (A) Adenomas
(shown by arrows) are visible on the surface of the lungs of wild type and CC10-Smad7 mice following exposure to urethane. Note that the number of
adenoma in the Smad7 transgenic mice is substantially increased. (B) Average number of tumors per mouse was largely increased in both male and
female CC10-Smad7 transgenic mice. The bars shown are average numbers in each group. (C) Gross histology of the lung tumors found in wild type
and CC10-Smad7 mice following urethane exposure.
doi:10.1371/journal.pone.0010149.g004
Smad7 in Asthma & Lung Cancer
PLoS ONE | www.plosone.org 10 April 2010 | Volume 5 | Issue 4 | e1014929. Burgess AW, Metcalf D (1980) The nature and action of granulocyte-
macrophage colony stimulating factors. Blood 56: 947–958.
30. Tomonaga M, Golde DW, Gasson JC (1986) Biosynthetic (recombinant) human
granulocyte-macrophage colony-stimulating factor: effect on normal bone
marrow and leukemia cell lines. Blood 67: 31–36.
31. Yamashita N, Tashimo H, Ishida H, Kaneko F, Nakano J, et al. (2002)
Attenuation of airway hyperresponsiveness in a murine asthma model by
neutralization of granulocyte-macrophage colony-stimulating factor (GM-CSF).
Cell Immunol 219: 92–97.
32. Pilette C, Francis JN, Till SJ, Durham SR (2004) CCR4 ligands are up-regulated
in the airways of atopic asthmatics after segmental allergen challenge. Eur
Respir J 23: 876–884.
33. Lai ST, Hung CH, Hua YM, Hsu SH, Jong YJ, et al. (2008) T-helper 1-related
chemokines in the exacerbation of childhood asthma. Pediatr Int 50: 99–102.
34. Barczyk A, Pierzchala W, Sozanska E (2003) Interleukin-17 in sputum correlates
with airway hyperresponsiveness to methacholine. Respir Med 97: 726–733.
35. Jeon HS, Dracheva T, Yang SH, Meerzaman D, Fukuoka J, et al. (2008)
SMAD6 contributes to patient survival in non-small cell lung cancer and its
knockdown reestablishes TGF-beta homeostasis in lung cancer cells. Cancer Res
68: 9686–9692.
36. Weaver CT, Hatton RD, Mangan PR, Harrington LE (2007) IL-17 family
cytokines and the expanding diversity of effector T cell lineages. Annu Rev
Immunol 25: 821–852.
37. Schnyder-Candrian S, Togbe D, Couillin I, Mercier I, Brombacher F, et al.
(2006) Interleukin-17 is a negative regulator of established allergic asthma. J Exp
Med 203: 2715–2725.
38. Nakae S, Komiyama Y, Nambu A, Sudo K, Iwase M, et al. (2002) Antigen-
specific T cell sensitization is impaired in IL-17-deficient mice, causing
suppression of allergic cellular and humoral responses. Immunity 17: 375–387.
39. Parkin DM (2001) Global cancer statistics in the year 2000. Lancet Oncol 2:
533–543.
40. Ozeki Y, Takishima K, Mamiya G (1994) Immunohistochemical analysis of
nm23/NDP kinase expression in human lung adenocarcinoma: association with
tumor progression in Clara cell type. Jpn J Cancer Res 85: 840–846.
41. Reynolds SD, Malkinson AM (2009) Clara cell: Progenitor for the bronchiolar
epithelium. Int J Biochem Cell Biol.
42. Kundu JK, Surh YJ (2008) Inflammation: gearing the journey to cancer. Mutat
Res 659: 15–30.
43. Balkwill F, Charles KA, Mantovani A (2005) Smoldering and polarized
inflammation in the initiation and promotion of malignant disease. Cancer Cell
7: 211–217.
44. Smyth MJ, Dunn GP, Schreiber RD (2006) Cancer immunosurveillance and
immunoediting: the roles of immunity in suppressing tumor development and
shaping tumor immunogenicity. Adv Immunol 90: 1–50.
45. Allavena P, Sica A, Garlanda C, Mantovani A (2008) The Yin-Yang of tumor-
associated macrophages in neoplastic progression and immune surveillance.
Immunol Rev 222: 155–161.
46. Acosta JC, O’Loghlen A, Banito A, Guijarro MV, Augert A, et al. (2008)
Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133:
1006–1018.
47. Kuilman T, Michaloglou C, Vredeveld LC, Douma S, van Doorn R, et al.
(2008) Oncogene-induced senescence relayed by an interleukin-dependent
inflammatory network. Cell 133: 1019–1031.
48. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, et al. (2006) Type,
density, and location of immune cells within human colorectal tumors predict
clinical outcome. Science 313: 1960–1964.
49. Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, et al. (2005) Effector
memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med
353: 2654–2666.
50. He J, Sun X, Qian KQ, Liu X, Wang Z, et al. (2009) Protection of cerulein-
induced pancreatic fibrosis by pancreas-specific expression of Smad7. Biochim
Biophys Acta 1792: 56–60.
51. Ding Q, Jin T, Wang Z, Chen Y (2007) Catalase potentiates retinoic acid-
induced THP-1 monocyte differentiation into macrophage through inhibition of
peroxisome proliferator-activated receptor gamma. J Leukoc Biol 81:
1568–1576.
52. McMillan SJ, Xanthou G, Lloyd CM (2005) Manipulation of allergen-induced
airway remodeling by treatment with anti-TGF-beta antibody: effect on the
Smad signaling pathway. J Immunol 174: 5774–5780.
Smad7 in Asthma & Lung Cancer
PLoS ONE | www.plosone.org 11 April 2010 | Volume 5 | Issue 4 | e10149